Arrow Financial’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-135
Closed -$5K 345
2019
Q1
$5K Sell
135
-90
-40% -$3.27K ﹤0.01% 311
2018
Q4
$6K Sell
225
-1,275
-85% -$40.3K ﹤0.01% 314
2018
Q3
$59K Hold
1,500
0.01% 214
2018
Q2
$67K Buy
+1,500
New +$74.6K 0.02% 195
2017
Q2
Sell
-80
Closed -$3K 338
2017
Q1
$3K Hold
80
﹤0.01% 325
2016
Q4
$2K Hold
80
﹤0.01% 327
2016
Q3
$1K Buy
+80
New +$914 ﹤0.01% 334
2016
Q2
Sell
-360
Closed -$3K 348
2016
Q1
$3K Hold
360
﹤0.01% 339
2015
Q4
$2K Sell
360
-90
-20% -$575 ﹤0.01% 425
2015
Q3
$3K Buy
+450
New +$4.71K ﹤0.01% 325

Other funds holding CC

Arrow Financial's CC Position: Q2 2019 in Review

Arrow Financial sold out of Chemours (CC) in Q2 2019, closing a stake of 135 shares — an estimated $5K sold.

Arrow Financial first reported a position in CC in Q3 2015 and held it in 10 quarters. The position peaked at $67K in Q2 2018. 488 funds tracked by Wall St. Rank hold CC as of Q2 2019.

  • Arrow Financial reported no remaining Chemours position as of Q2 2019 after selling out during the quarter.
  • Arrow Financial sold 135 Chemours shares in Q2 2019, an estimated $5K.
  • Arrow Financial first reported a position in Chemours in Q3 2015 and held it in 10 quarters.
  • Arrow Financial's Chemours position peaked at $67K in Q2 2018.
  • 488 funds tracked by Wall St. Rank held Chemours as of Q2 2019.

Based on Arrow Financial's 13F filing for Q2 2019, filed 26 Jul 2019.